Studies have shown that neoadjuvant nivolumab may provide long-term benefits for people with non-small cell lung cancer.

Published Date: 17 Feb 2023

BACKGROUND: NSCLC is the most common and important cause of cancer worldwide. Assessment: The patient...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Year in Review: Non-Small Cell Lung Cancer

2.

Study suggests around 40% of postmenopausal hormone positive breast cancers are linked to excess body fat

3.

The need for more Latinx participants in Alzheimer's trials is urgent.

4.

Why palliative care goes hand in hand with treatment for people with cancer: Q&A

5.

MRD-Guided Azacitidine May Delay Relapse in AML, MDS


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot